KELLY BALESTRA: Open Payments
NPI 1477884203 · KEY WEST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 23 payments from 8 companies in 2025. Trend: 2023 $402 · 2024 $579 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $215 |
| GENZYME CORPORATION | 1 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Galderma Laboratories, L.P. | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| LEO Pharma Inc. | 2 | $40 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $15 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, COSENTYX, EBGLYSS, ADBRY, BOTOX.
Industry payments across FL — which companies pay providers there.
